Insider trades
Helen Torley, CEO of Halozyme Therapeutics HALO, has filed 0 purchases and 124 sales on the open market. Over the past 12 months that comes to a net sale of $24.1M. The latest trade was on 06/03.
Helen Torley
President and CEO
- Company
- Halozyme Therapeutics HALO
- First filing
- 23/01/19
- Trades
- 324 trades
- Buys / sales
- 0 / 124
- 12-month net buying
- −$24.1M
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/01–06/03 | 06/03 | 50,000 sh9 trades | $67.40avg. | $3,369,987.74 | −6.1% | |
| Open-market sale10b5-1 plan | 05/11–05/13 | 05/13 | 50,000 sh12 trades | $68.68avg. | $3,433,911.91 | −6.1% | |
| Open-market sale10b5-1 plan | 04/06 | 04/07 | 10,000 sh2 trades | $63.50avg. | $635,008 | −1.3% | |
| Open-market sale10b5-1 plan | 04/01–04/02 | 04/02 | 40,000 sh4 trades | $64.81avg. | $2,592,236 | −5.0% | |
| Open-market sale10b5-1 plan | 03/02–03/04 | 03/04 | 50,000 sh7 trades | $69.52avg. | $3,476,148.31 | −6.1% | |
| Open-market sale10b5-1 plan | 02/03–02/05 | 02/05 | 50,000 sh7 trades | $77.07avg. | $3,853,499.48 | −6.6% | |
| Open-market sale10b5-1 plan | 25/12/01 | 25/12/01 | 16,569 sh4 trades | $68.92avg. | $1,141,897.54 | −2.3% | |
| Open-market sale10b5-1 plan | 25/11/10–25/11/12 | 25/11/12 | 60,000 sh8 trades | $69.46avg. | $4,167,883.18 | −7.6% | |
| Open-market sale10b5-1 plan | 25/10/01–25/10/03 | 25/10/03 | 60,000 sh11 trades | $71.86avg. | $4,311,738.91 | −7.6% | |
| Open-market sale10b5-1 plan | 25/09/02–25/09/04 | 25/09/04 | 60,000 sh8 trades | $74.08avg. | $4,444,703.4 | −7.6% | |
| Open-market sale10b5-1 plan | 25/08/11–25/08/13 | 25/08/13 | 60,000 sh6 trades | $63.62avg. | $3,817,480.41 | −7.6% | |
| Open-market sale10b5-1 plan | 25/07/08–25/07/10 | 25/07/10 | 60,000 sh6 trades | $56.46avg. | $3,387,658.2 | −7.6% | |
| Open-market sale10b5-1 plan | 25/06/20–25/06/24 | 25/06/24 | 60,000 sh4 trades | $53.09avg. | $3,185,208.8 | −7.6% | |
| Open-market sale10b5-1 plan | 24/10/08–24/10/09 | 24/10/09 | 20,000 sh5 trades | $53.29avg. | $1,065,777.14 | −2.9% | |
| Open-market sale10b5-1 plan | 24/09/24–24/09/26 | 24/09/26 | 30,000 sh3 trades | $56.88avg. | $1,706,500 | −4.2% | |
| Open-market sale10b5-1 plan | 24/09/10–24/09/12 | 24/09/12 | 30,000 sh3 trades | $59.13avg. | $1,773,800 | −4.2% | |
| Open-market sale10b5-1 plan | 24/08/13–24/08/15 | 24/08/15 | 30,000 sh5 trades | $57.15avg. | $1,714,460.87 | −4.2% | |
| Open-market sale10b5-1 plan | 23/08/29–23/08/31 | 23/08/31 | 30,000 sh3 trades | $42.69avg. | $1,280,700 | −4.6% | |
| Open-market sale10b5-1 plan | 23/08/15–23/08/17 | 23/08/17 | 30,000 sh3 trades | $43.49avg. | $1,304,800 | −4.6% | |
| Open-market sale10b5-1 plan | 23/07/25–23/07/27 | 23/07/27 | 30,000 sh3 trades | $43.09avg. | $1,292,800 | −4.6% |